Epidermal Growth Factor Receptor Mutation Status and the Impact on Clinical Outcomes in Patients with Non-Small Cell Lung Cancer.

Huang, H M; Wei, Y; Wang, J J; Ran, F Y; Wen, Y; Chen, Q H; Zhang, B F

Huang, H M; Wei, Y; Wang, J J; Ran, F Y; Wen, Y; Chen, Q H; Zhang, B F.

Afiliación

Huang HM; Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, 442008, China.
Wei Y; Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, 442008, China.
Wang JJ; Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, 442008, China.
Ran FY; Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, 442008, China.
Wen Y; School of Public Health, Xi'an Jiaotong University, Xi'an, 710003, China.
Chen QH; Department of Pharmacy, Shenzhen Baoan Authentic TCM Therapy Hospital, Shenzhen, 518101, China.
Zhang BF; Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, 442008, China.

Balkan J Med Genet ; 25(2): 29-36, 2023 May.

Article en En | MEDLINE | ID: mdl-37265968

Palabras clave

Epidemiological characteristics; Epidermal growth factor receptor; Mutations; Non-small cell lung cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Balkan J Med Genet Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Polonia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google